Showing results (321-330 of 349) with videos related to
Sort By:
Pageof 35
Carcinogenesis|February 22, 2021
Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virusHaruhiko Takeda, Atsushi Takai, Eriko Iguchi, et al.Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|June 9, 2022
Clinical outcomes in pregnant women with coronavirus disease 2019 in a perinatal medical centre in Japan: a retrospective study of the first 1 year of the pandemicKen Takahashi, Yukari Kobayashi, Mariko Sato, et al.Journal of Gastroenterology|February 27, 2022
Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human expertsNaoshi Nishida, Makoto Yamakawa, Tsuyoshi Shiina, et al.Veterinary Sciences|November 24, 2023
Adipose Stem Cell-Seeded Decellularized Porcine Pericardium: A Promising Functional Biomaterial to Synergistically Restore the Cardiac Functions Post-Myocardial InfarctionHussein M El-Husseiny, Eman A Mady, Tatsuya Usui, et al.Cancer Research|April 1, 2022
Expansion of Gastric Intestinal Metaplasia with Copy Number Aberrations Contributes to Field CancerizationKen Kumagai, Takahiro Shimizu, Atsushi Takai, et al.Cancer Research|August 17, 2006
Quantitative detection of p53 mutations in plasma DNA from tobacco smokersNobutoshi Hagiwara, Leah E Mechanic, Glenwood E Trivers, et al.Journal of Gastroenterology|September 17, 2024
CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective studyMasayuki Ueno, Haruhiko Takeda, Atsushi Takai, et al.Redox Biology|September 9, 2025
Monitoring ferroptosis in vivo: Iron-driven volatile oxidized lipids as breath biomarkersYuta Matsuoka, Yoshinori Katsumata, Po-Sung Chu, et al.Endoscopy|September 22, 2020
A novel technique for mapping biopsy of bile duct cancerHirokazu Okada, Norimitsu Uza, Tomoaki Matsumori, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 13, 2025
Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective StudyMasayuki Ueno, Haruhiko Takeda, Atsushi Takai, et al.Pageof 35